Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lepu Scientech Medical Technology (Shanghai) Co has a current ratio of 23.54. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
HKSE:02291's Current Ratio is ranked better than 98.82% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 2.43
vs HKSE:02291: 23.54
Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Lepu Scientech Medical Technology (Shanghai) Co Current Ratio Related Terms
Lepu Scientech Medical Technology (Shanghai) Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lepu Scientech Medical Technology (Shanghai) Co Current Ratio Chart
Lepu Scientech Medical Technology (Shanghai) Co Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lepu Scientech Medical Technology (Shanghai) Co Current Ratio vs Medical Devices & Instruments Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) has a Current Ratio of 23.54 as of Dec. 2025. This is 40% above median its historical median of 16.79. Over the past decade, Lepu Scientech Medical Technology (Shanghai) Co's Current Ratio has ranged from 1.09 to 23.90. According to the industry distribution chart, Lepu Scientech Medical Technology (Shanghai) Co ranks #10 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 1.2%.
Is Lepu Scientech Medical Technology (Shanghai) Co's Current Ratio too high?
Lepu Scientech Medical Technology (Shanghai) Co's current Current Ratio of 23.54 is 40% above median its 10-year median of 16.79. Over the past 10 years, this metric has ranged from a low of 1.09 to a high of 23.90. The Medical Devices & Instruments industry median Current Ratio is 2.43. Lepu Scientech Medical Technology (Shanghai) Co's value of 23.54 is 868.7% above this industry median. Based on the distribution chart, Lepu Scientech Medical Technology (Shanghai) Co ranks #10 out of 851 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Lepu Scientech Medical Technology (Shanghai) Co has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lepu Scientech Medical Technology (Shanghai) Co's Current Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Lepu Scientech Medical Technology (Shanghai) Co ranks #10 out of 851 companies for Current Ratio. This places Lepu Scientech Medical Technology (Shanghai) Co in the top 1% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.43. Lepu Scientech Medical Technology (Shanghai) Co's value of 23.54 is 868.7% above this benchmark. Historically, Lepu Scientech Medical Technology (Shanghai) Co's own Current Ratio has ranged from 1.09 to 23.90 over the past decade. While the company's 10-year median is 16.79 vs. the industry median of 2.43, Lepu Scientech Medical Technology (Shanghai) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.43, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lepu Scientech Medical Technology (Shanghai) Co's current Current Ratio of 23.54 is 868.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lepu Scientech Medical Technology (Shanghai) Co's current Current Ratio is 23.54, which is 40% above median its own 10-year median of 16.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lepu Scientech Medical Technology (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$44.35, compared to a current price of HK$14.68 — trading 66.9% below its estimated fair value. The current Current Ratio is 23.54, which is 40% above median its 10-year median of 16.79 and 868.7% above the Medical Devices & Instruments industry median of 2.43. Lepu Scientech Medical Technology (Shanghai) Co's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291), the current Current Ratio is 23.54 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Overvalued in 2026?
Based on GuruFocus' analysis, Lepu Scientech Medical Technology (Shanghai) Co stock appears to be undervalued.
The current stock price of HK$14.68 is trading 66.9% below its estimated GF Value™ of HK$44.35.
GuruFocus considers Lepu Scientech Medical Technology (Shanghai) Co to be Significantly Undervalued.
Key valuation signals for HKSE:02291:
Current Ratio: 23.54 (40% above median its 10-year median of 16.79)
GF Value™: HK$44.35 vs. price of HK$14.68 (66.9% below fair value)
Industry Position: 868.7% above the Medical Devices & Instruments median (#10 of 851)
No single metric tells the full story. See the HKSE:02291 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lepu Scientech Medical Technology (Shanghai) Co Ltd is focused on the research and development, manufacture, and commercialization of heart disease interventional medical devices. The reporting segments of the Group are as follows: The Occluder business segment and The heart valve business segment. The company generates majority of its revenue from the Occluder segment which is engaged in the research and development, manufacturing and sales of interventional treatment series occluders for the defective congenital heart disease.
76GF Score
Get the complete analysis for HKSE:02291
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02291 has been successfully added to your 
